RHOPRESSA contains the active ingredient netarsudil in the form of netarsudil dimesylate, which is a Rho kinase inhibitor. It is available as a 0.02% ophthalmic solution and is intended for topical application in the eye. Inactive ingredients include benzalkonium chloride, boric acid, mannitol, sodium hydroxide, and water for injection.
How should I use this medication?
This medication is only for use in the eye. Do not take by mouth. Follow the directions on the prescription label. Wash hands before and after use. Tilt the head back slightly and pull down the lower lid with the index finger to form a pouch. Try not to touch the tip of the dropper to your eye or any other surface. Squeeze one drop into the pouch. Close the eye gently. Do not blink or rub your eyes. Apply pressure to the inside corner of your eye for a few minutes after placing the medication to help it stay in your eye longer. Use your doses at regular intervals. Do not use your medication more often than directed. Talk to your care team about the use of this medication in children. Special care may be needed.
Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others.
What if I miss a dose?
If you miss a dose, continue with the next dose in the evening. Do not take double or extra doses.
Where should I keep my medication?
Keep out of the reach of children and pets. Store in the refrigerator between 2 and 8 degrees C (36 and 46 degrees F) until opened. After opening, the product may be stored in the refrigerator or at room temperature between 2 and 25 degrees C (36 and 77 degrees F) for up to 6 weeks. If after opening the product is kept in the refrigerator at 2 to 8 degrees C (36 to 46 degrees F), the product can be used until the expiration date stamped on the bottle. Throw away any unused medication after the expiration date.
NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.
What side effects may I notice from receiving this medication?
Side effects that you should report to your care team as soon as possible: -Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat -Change in vision -New or worsening eye pain, redness, irritation, or discharge Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome): -Blurry vision -Change in eye, eyelash, or eyelid color -Eye irritation or itching -Increased tears after use
This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What should I tell my care team before I take this medication?
They need to know if you have any of these conditions: -Eye infection or damage -Wear contact lenses -An unusual or allergic reaction to netarsudil, benzalkonium chloride, other medications, foods, dyes, or preservatives -Pregnant or trying to get pregnant -Breast-feeding
What may interact with this medication?
Do not use any other eye products without telling your care team.
This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.
What should I watch for while using this medication?
Visit your care team for regular checks on your progress. Report any serious side effects right away. Stop using this medication if your eyes get swollen, painful, or have a discharge, and see your care team as soon as you can. If you wear contact lenses, take them out before using this medication. Wait 15 minutes before putting them back into your eyes. If you are using another eye medication, wait at least 5 minutes in between using each medication.
Source: This information is sourced from Elsevier Inc.
The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.
Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.
Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.
Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool).
Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc. Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”). Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.